Search research articles
Contact Us
Filters
Showing results (91-100 of 402) with videos related to
Page
of 41
Sort By:
The American Journal of Managed Care
|
March 22, 2023
Neulasta Onpro: a coup de grâce?
Chelsee J Jensen, Caleb J Scheckel, Ronald S Go, et al.
Leukemia Research
|
December 17, 2021
Risk of mortality and second malignancies in primary myelofibrosis before and after ruxolitinib approval
John W Thomas, Omer Jamy, Mithun Vinod Shah, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 4, 2017
<sup>18</sup>F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker
Jason R Young, Geoffrey B Johnson, Robert C Murphy, et al.
American Journal of Clinical Oncology
|
February 13, 2014
Speed of Accrual Into Phase III Oncology Trials: A Comparison Across Geographic Locations
Nancy R Ruther, Michelle A Mathiason, Sandra K Wee, et al.
American Journal of Clinical Oncology
|
February 6, 2009
Extent and nature of advertising in leading hematology-oncology journals
Debbie L Sieber, Jennifer A Lee, Michelle A Mathiason, et al.
Advances in Radiation Oncology
|
February 3, 2025
Hypofractionated Radiation Therapy for Subcutaneous Rosai-Dorfman Disease: A Case Report
Rachael M Guenzel, William G Breen, Ronald S Go, et al.
The American Journal of Managed Care
|
May 25, 2023
Provider barriers in uptake of biosimilars: case study on filgrastim
Jessica Chang, Pinar Karaca-Mandic, Ronald S Go, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
September 19, 2018
Monoclonal Gammopathy of Undetermined Significance: Follow-up Patterns in the United States and Concordance With Clinical Practice Guidelines
Ronald S Go, Herbert C Heien, Lindsey R Sangaralingham, et al.
Haematologica
|
December 23, 2017
Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: determining demographic differences in the USA
Ronald S Go, Herbert C Heien, Lindsey R Sangaralingham, et al.
The American Journal of Managed Care
|
August 30, 2021
Site of care potentially limits cost savings from biosimilars
Jessica Chang, Pinar Karaca-Mandic, Ronald S Go, et al.
Page
of 41
Search research articles
Search
Showing results (91-100 of 402) with videos related to
Sort By:
Page
of 41
The American Journal of Managed Care
|
March 22, 2023
Neulasta Onpro: a coup de grâce?
Chelsee J Jensen, Caleb J Scheckel, Ronald S Go, et al.
Leukemia Research
|
December 17, 2021
Risk of mortality and second malignancies in primary myelofibrosis before and after ruxolitinib approval
John W Thomas, Omer Jamy, Mithun Vinod Shah, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 4, 2017
<sup>18</sup>F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker
Jason R Young, Geoffrey B Johnson, Robert C Murphy, et al.
American Journal of Clinical Oncology
|
February 13, 2014
Speed of Accrual Into Phase III Oncology Trials: A Comparison Across Geographic Locations
Nancy R Ruther, Michelle A Mathiason, Sandra K Wee, et al.
American Journal of Clinical Oncology
|
February 6, 2009
Extent and nature of advertising in leading hematology-oncology journals
Debbie L Sieber, Jennifer A Lee, Michelle A Mathiason, et al.
Advances in Radiation Oncology
|
February 3, 2025
Hypofractionated Radiation Therapy for Subcutaneous Rosai-Dorfman Disease: A Case Report
Rachael M Guenzel, William G Breen, Ronald S Go, et al.
The American Journal of Managed Care
|
May 25, 2023
Provider barriers in uptake of biosimilars: case study on filgrastim
Jessica Chang, Pinar Karaca-Mandic, Ronald S Go, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
September 19, 2018
Monoclonal Gammopathy of Undetermined Significance: Follow-up Patterns in the United States and Concordance With Clinical Practice Guidelines
Ronald S Go, Herbert C Heien, Lindsey R Sangaralingham, et al.
Haematologica
|
December 23, 2017
Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: determining demographic differences in the USA
Ronald S Go, Herbert C Heien, Lindsey R Sangaralingham, et al.
The American Journal of Managed Care
|
August 30, 2021
Site of care potentially limits cost savings from biosimilars
Jessica Chang, Pinar Karaca-Mandic, Ronald S Go, et al.
Page
of 41